Research.Patient.info
Advanced Hepatocellular Carcinoma research hub
3 indexed studies · 0 currently recruiting
- ongoing, recruitingTherapeutic exploratory (Phase II)
A Phase 2, Randomized, Open-label Study of Relatlimab in Combination with Nivolumab in Participants with Advanced Hepatocellular Carcinoma who are Naive to IO Therapy but Progressed on Tyrosine Kinase Inhibitors (RELATIVITY-073)
This study is looking at a new combination of two medicines, nivolumab and relatlimab, for adults with advanced liver cancer that has progressed despite previous treatments. It aims to see how well this new combination shrinks tumors and if it's safe.
Romania · Poland · Spain - ongoing, recruitingPhase I and Phase II (Integrated)- Other
A phase I study evaluating safety and efficacy of Hepatic Intra- Arterial administration of ipilimumab in combination with Intra- venous nivolumab for advanced Hepatocellular carcinoma (HIPANIV)
This study is looking at a new way to treat advanced liver cancer. It combines two existing medicines, ipilimumab and nivolumab, given in a special way to see if it's safe and works well. This early-stage trial aims to find the best dose.
France - active not recruitingPHASE3
Durvalumab and Tremelimumab as First Line Treatment in Participants With Advanced Hepatocellular Carcinoma (HCC)
This study looks at two drugs, durvalumab and tremelimumab, as a first treatment for advanced liver cancer that can't be removed by surgery. Researchers want to see how safe and effective this combination is.
United States · France · Germany